"Innovation is a lasting improvement to the overall effectiveness of the way a society functions," according to Patrice Noailles, President of Seillans Investissement, France.
Noailles told the Pharmapack audience in Paris that innovation has often been defined as "a new product that sells." But, in his presentation "From Mesopotamia to modern times, THINK DIFFERENT about INNOVATION," he challenged attendees to consider his more substantial economic definition. This improved effectiveness results from the creation of new products, new services, new working methods and new forms of organization.
Innovation, says Noailles, is essential for wealth and power, and if population growth will expand to 10 billion in habitants on Earth, innovation is going to be essential, or we will be inundated with garbage and unable to gather enough raw materials and food to sustain ourselves.
When considering innovation in drug packaging, Noailles says that you must first consider that drugs are the most efficient way of reducing healthcare costs. It is far less expensive to vaccinate against an illness than it is to treat the illness. So, it's important for drugs, drug delivery and drug packaging to continue to be innovative to drive costs down.
And, as we look into the future, Noailles predicts that, due to the rising number of elderly persons worldwide, drug innovation will shift from epidemics and sickness to medications that combat aging, and conditions related to aging. Noailles says that in the future, we should be on the lookout for new functions of packaging that contribute to "delivery control", which, when combined with authentication and protection of drugs, will help make significant productivity gains.
Noailles told the Pharmapack audience in Paris that innovation has often been defined as "a new product that sells." But, in his presentation "From Mesopotamia to modern times, THINK DIFFERENT about INNOVATION," he challenged attendees to consider his more substantial economic definition. This improved effectiveness results from the creation of new products, new services, new working methods and new forms of organization.
Innovation, says Noailles, is essential for wealth and power, and if population growth will expand to 10 billion in habitants on Earth, innovation is going to be essential, or we will be inundated with garbage and unable to gather enough raw materials and food to sustain ourselves.
When considering innovation in drug packaging, Noailles says that you must first consider that drugs are the most efficient way of reducing healthcare costs. It is far less expensive to vaccinate against an illness than it is to treat the illness. So, it's important for drugs, drug delivery and drug packaging to continue to be innovative to drive costs down.
And, as we look into the future, Noailles predicts that, due to the rising number of elderly persons worldwide, drug innovation will shift from epidemics and sickness to medications that combat aging, and conditions related to aging. Noailles says that in the future, we should be on the lookout for new functions of packaging that contribute to "delivery control", which, when combined with authentication and protection of drugs, will help make significant productivity gains.
